Abstract

Prostate cancer (PCa) is a major health problem in males. Metastasis-associated with lung adenocarcinoma transcript-1 (MALAT1), which is overexpressed in PCa tissue, is associated with physiological and pathological conditions of PCa. M2 macrophages are major immune cells abundant in the tumor microenvironment. However, it remains unknown whether M2 macrophages are involved in the effects or not, and molecular mechanisms of MALAT1 on PCa progression have not yet been comprehensively explored. Here we reported that, M2 macrophages (PMA/IL-4 treated THP1) induced MALAT1 expression in PCa cell lines. Knockdown MALAT1 expression level in PCa cell lines inhibited cellular proliferation, invasion, and tumor formation. Further mechanistic dissection revealed that M2 macrophages secreted IL-8 was sufficient to drive up MALAT1 expression level via activating STAT3 signaling pathway. Additional chromatin immunoprecipitation (ChIP) and luciferase reporter assays displayed that STAT3 could bind to the MALAT1 promoter region and transcriptionally stimulate the MALAT1 expression. In summary, our present study identified the IL-8/STAT3/MALAT1 axis as key regulators during prostate tumorigenesis and therefore demonstrated a new mechanism for the MALAT1 transcriptional regulation.

Highlights

  • Prostate cancer (PCa) is a major health problem in men

  • This study demonstrated that Metastasis-associated with lung adenocarcinoma transcript-1 (MALAT1) overexpression modified by M2 macrophages promoted prostate tumorigenesis via STAT3/MALAT1 pathway

  • The expression of macrophages surface marker CD68 and M2 macrophages surface marker CD206 increased dramatically in THP-1 cells, implying that THP-1 cell treated with PMA/IL-4 appeared to successfully differentiate into M2 macrophages (Figure 1A)

Read more

Summary

Introduction

Therapeutic progress in PCa includes the approval of radiation therapy and either androgen-deprivation therapy or anti-androgen therapy prolongs survival among some patients with an intact prostate [1]. Despite these therapeutic advances, PCa remains the second leading cause of morbidity and is the third leading cause of male cancer death in the western world [1,2,3]. Many groups of stromal cells, including angiogenic vascular cells, infiltrating immune cells, and cancer-associated fibroblastic cells, have been demonstrated infiltrating in TME [9,10]. Thorpe and colleagues certified that stromal cells produced the IL-8 into the PCa environment and increasing the metastatic properties of PCa cells [17]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.